Jeremy Grantham’s Latest Portfolio: Microsoft, Alphabet Dominate GMO Holdings

Microsoft and Alphabet comprise the dominant holdings in GMO's $39.1 billion equity portfolio, signaling continued conviction in mega-cap technology dominance. This concentration reflects the asset manager's thesis on durable competitive advantages and structural moats protecting cash generation for large-cap tech leaders.

The portfolio maintains broad diversification across technology, healthcare, financials, and industrials sectors, suggesting GMO is not executing a narrow sector bet but rather applying quality-screen criteria across multiple verticals. This balanced exposure indicates an institutional focus on business fundamentals rather than momentum-driven rotation strategies.

The holding pattern reveals Grantham's continued emphasis on earnings power and long-term value creation over cyclical growth narratives. Large-cap concentration in mega-cap tech reflects both valuation efficiency and the difficulty of finding comparable quality alternatives in secondary market segments at current macro conditions.

Sector implication: Technology maintains structural appeal within systematic quality frameworks, while healthcare and financials provide portfolio ballast. This composition suggests limited portfolio repositioning in recent quarters, with managers maintaining conviction in existing positions rather than responding to near-term market sentiment shifts.